Literature DB >> 19375765

Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery.

Madeleine L Heath1, Lilian Kow, John P Slavotinek, Robin Valentine, Jim Toouli, Campbell H Thompson.   

Abstract

Weight loss after laparoscopic adjustable gastric banding surgery (LAGB) is associated with mobilization of adipose tissue from a variety of depots. We sought to evaluate and relate abdominal and hepatic lipid deposition in an obese female population 3 and 12 months after LAGB. We related changes in these depots to markers of insulin sensitivity. Eighteen female obese subjects underwent magnetic resonance imaging and spectroscopy before and 3 and 12 months after LAGB for the quantification of abdominal subcutaneous (ABSAT) and visceral (VAT) adipose tissue areas and liver fat content (LFAT). Fasting blood free fatty acids (FFA) were analyzed. Insulin sensitivity was assessed by the homeostasis model assessment of insulin resistance index (HOMA-R). Mean weight loss 3 and 12 months after LAGB was 9.8 +/- 1.1 kg and 20.0 +/- 2.2 kg, respectively. Postoperatively, VAT area loss exceeded ABSAT area loss in the cohort as a whole and when divided according to preoperative liver fat stores. Three months after LAGB, reductions had occurred in VAT and ABSAT areas (both P < .01) and in FFA (P < .05). Twelve months after LAGB, further significant reductions (P < .01) occurred in VAT and ABSAT areas but not in FFA. No significant reduction occurred in LFAT at either time point in the group as a whole. In those with preoperative hepatic steatosis (LFAT > approximately 5%, n = 7), LFAT fell by 42% (P = .036) 3 months after LAGB, with a total reduction of 50% (P = .027 cf baseline) occurring by 12 months. There was an improvement in HOMA-R at 12 months (1.9 +/- 0.3 cf 2.9 +/- 0.5 at baseline, P = .04) but not 3 months (2.7 +/- 0.4). Preoperatively, LFAT related significantly to VAT area (r = 0.67, P = .003) and HOMA-R (r = 0.497, P = .04) but not ABSAT area. Postoperatively at both 3 and 12 months, LFAT continued to relate to VAT area (r = 0.63, P < .01 at both time points) but not HOMA-R. The changes in LFAT and VAT area were unrelated postoperatively. Abdominal adipose tissue loss was greater from the visceral than subcutaneous depots, suggesting that insulin sensitivity may not be an important determinant of selective lipid depot loss. The lack of a significant change in liver fat in the group as a whole may relate to low preoperative liver fat stores and to high postoperative dietary fat intakes. Preoperative liver fat stores did not influence insulin sensitivity or abdominal lipid changes during weight loss. Liver fat content and VAT area interrelated more closely than either related to ABSAT area, suggesting differing regulatory pathways for fat mobilization from ABSAT and VAT depots but possibly similar pathways for storage and mobilization of fat in the liver and viscerally.

Entities:  

Mesh:

Year:  2009        PMID: 19375765     DOI: 10.1016/j.metabol.2008.05.021

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  18 in total

1.  Ultrasound evaluation of visceral and subcutaneous fat reduction in morbidly obese subjects undergoing laparoscopic gastric banding, sleeve gastrectomy, and Roux-en-Y gastric bypass: a prospective comparison study.

Authors:  Ido Mizrahi; Nahum Beglaibter; Natalia Simanovsky; Natali Lioubashevsky; Haggi Mazeh; Muhammad Ghanem; Katya Chapchay; Ahmed Eid; Ronit Grinbaum
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

Review 2.  Quantification of liver fat with magnetic resonance imaging.

Authors:  Scott B Reeder; Claude B Sirlin
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

Review 3.  Liver fat content determined by magnetic resonance imaging and spectroscopy.

Authors:  Fabian Springer; Jürgen Machann; Claus D Claussen; Fritz Schick; Nina F Schwenzer
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 4.  Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis.

Authors:  C Merlotti; V Ceriani; A Morabito; A E Pontiroli
Journal:  Int J Obes (Lond)       Date:  2017-02-02       Impact factor: 5.095

5.  Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction.

Authors:  Dennis M Hedderich; Till Hasenberg; Stefan Haneder; Stefan O Schoenberg; Özlem Kücükoglu; Ali Canbay; Mirko Otto
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

6.  Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery.

Authors:  Christos G Galanakis; Markos Daskalakis; Andreas Manios; Argyro Xyda; Apostolos H Karantanas; John Melissas
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

7.  Quantification of Liver, Subcutaneous, and Visceral Adipose Tissues by MRI Before and After Bariatric Surgery.

Authors:  Anne Christin Meyer-Gerspach; Ralph Peterli; Michael Moor; Philipp Madörin; Andreas Schötzau; Diana Nabers; Stefan Borgwardt; Christoph Beglinger; Oliver Bieri; Bettina K Wölnerhanssen
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

8.  Baseline abdominal lipid partitioning is associated with the metabolic response to bariatric surgery.

Authors:  Andrei Keidar; Liat Appelbaum; Chaya Schweiger; Karen Hershkop; Idit Matot; Naama Constantini; Jacob Sosna; Ram Weiss
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

9.  Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding.

Authors:  Mousumi Bose; Sriram Machineni; Blanca Oliván; Julio Teixeira; James J McGinty; Baani Bawa; Ninan Koshy; Antonia Colarusso; Blandine Laferrère
Journal:  Obesity (Silver Spring)       Date:  2010-01-07       Impact factor: 5.002

10.  Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS study.

Authors:  Jing Qi; Yuman Fong; Leonard Saltz; Michael I D'Angelica; Nancy E Kemeny; Mithat Gonen; Jinru Shia; Amita Shukla-Dave; William R Jarnagin; William M Jarnagin; Richard K G Do; Lawrence H Schwartz; Jason A Koutcher; Kristen L Zakian
Journal:  NMR Biomed       Date:  2012-09-07       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.